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Abstract
Introduction: Respiratory manifestations of gastroesophageal reflux disease (GERD), particularly chronic
cough, are being recognized with increased frequency in children. This survey aimed to investigate the efficacy
of laparoscopic Nissen fundoplication for treatment of GERD-related respiratory symptoms not responsive to
medical therapy in neurological normal children.
Materials and Methods: We collected data of children with GERD-related respiratory complaints not re-
sponsive to medical therapy who underwent laparoscopic Nissen fundoplication in four European centers of
Pediatric Surgery over a 10-year period. We excluded children with neurological impairment.
Results: A total of 220 laparoscopic Nissen procedures were performed in the period 2005–2015. Twenty-four
(12 boys and 12 girls, average age 9.5 years) out of the 220 patients (10.9%) presented with chronic cough and
other respiratory manifestations, including asthma, reactive airway disease, and recurrent pneumonia. Average
operative time was 65 minutes (range 45–100). As for postoperative complications, two tight wraps requiring
endoscopic dilatation (IIIb Clavien) and two relapses of GERD for slipped Nissen requiring reoperation (IIIb
Clavien) were recorded. None of these complications occurred in the group of patients with GERD-related
respiratory symptoms. At follow-up evaluation, respiratory symptoms disappeared with a significant im-
provement of quality of life scoring (I Grade Visick) in 22/24 patients (91.6%).
Conclusion: Our results confirm that GERD should be investigated as one of the possible etiologic factors in any
child with persistent respiratory complaints. In patients with symptoms not responsive to medical therapy, laparo-
scopic Nissen fundoplication is the treatment of choicewith a very high success rate (>90% in our series), a very low
morbidity, a significant improvement in airway symptoms, and a marked reduction in the need for medications.
Keywords: respiratory symptoms, cough, medical therapy, Nissen, children
Introduction
Gastroesophageal reflux disease (GERD) representsthe second most common cause of chronic cough in
adult population.1 Respiratory manifestations of GERD,
particularly chronic cough, are also being recognized with
increased frequency in children.2–4 In a consistent number of
patients with respiratory disorders, gastroesophageal reflux
(GER) may be the sole cause of symptoms.5
Several mechanisms have been claimed to play a role in
GERD-related cough, including the effect of refluxate on the
esophagus, larynx, or bronchi. There are two main mecha-
nisms in the pathogenesis of GERD-related cough. The first
one is named ‘‘esophago-bronchial reflex,’’ and it is based on
shared vagal innervations of the distal esophagus and air-
ways. According to this theory, distal esophageal sensory
nerve terminals stimulated by refluxate activate a reflex re-
sulting in cough. The second mechanism is microaspiration,
in which refluxate reaches the airways through the proximal
esophagus and larynx directly resulting in cough. The risk of
microaspiration is thought to be increased by decreased
sensitivity of protective laryngeal and pharyngeal reflexes,
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impaired coordination of swallowing, and esophageal dys-
motility.6,7
Different techniques, such as simultaneous measurement
of esophageal and tracheal pH, scintigraphic scans of the
lungs, detection of pepsin in bronchoalveolar lavage (BAL)
or saliva, and detection of bile acids and lipid-laden alveolar
macrophages (LLAMs) in airway specimens, have been used
to identify microaspiration of refluxate into airways. Studies
on those measurement techniques have been conducted in
pediatric populations.8–11
Early diagnosis and antireflux medical therapy in cases
with GERD-related respiratory complaints can result in sig-
nificant improvement in symptoms.12,13 However, in patients
not responsive to medical therapy, laparoscopic GER surgery
improves airway symptoms with a success rate variable from
70% to 100%. The majority of these reports are focused on
adult population.14–16
Very limited data are available in the literature about the
role of laparoscopic GER surgery for treatment of GERD-
related respiratory symptoms in pediatric patients.17–20
In the majority of cases, pediatric gastroenterologists are
very reluctant to confirm the indications for surgery in pe-
diatric patients with GER and persistent respiratory symp-
toms because they prefer to continue to treat these patients
with only medical therapy.
This survey aimed to investigate the efficacy of laparo-
scopic Nissen fundoplication for treatment of GERD-related
respiratory symptoms not responsive to medical therapy in
neurological normal children.
Materials and Methods
We collected the data of children with GERD-related
chronic cough and other respiratory complaints not respon-
sive to medical antireflux therapy who underwent laparo-
scopic Nissen fundoplication in four European centers of
Pediatric Surgery over a 10-year period (2005–2015).
The exclusion criteria were as follows: neurological im-
pairment, congenital heart disease, tracheoesophageal fistula,
presence of ear-nose-throat pathologies, immunosuppres-
sion, any other disease that can lead to aspiration, and find-
ings compatible with upper airway cough syndrome.
All patients included in the study presented persistent re-
spiratory symptoms beyond 8 weeks (such as cough, wheeze,
asthma, respiratory distress, and bronchopneumonia) or recur-
rence of respiratory symptoms (more than twice a year for two
consecutive years) thatwere refractory to anadequate antireflux
medical treatment which included both nonpharmacological
therapy (frequent small thickened feeds, prone/upright position
during waking hours) and pharmacological therapy (proki-
netics, H2 blockers, and proton pump inhibitors [PPI] in ap-
propriate dosages) for at least 6–12 months.
Preoperative workup included chest X-ray and pH-
impedenziometry in all patients. Esophageal pH examination
results were considered positive for GERD-related respiratory
symptoms if they were pathologic or if there was a significant
correlation between symptoms and pH drop in the distal and
proximal recording channels (a pH drop of <4 during the
respiratory symptom period was considered significant).
Upper gastrointestinal endoscopy was performed to iden-
tify gross abnormalities in the esophagus, such as mucosal
erythema, linear ulceration, bleeding, and stricture. Upper
airway and bronchial endoscopy associated with BAL was
performed in only one center to assess the LLAM scoring and
to demonstrate aspiration events.
Indications for fundoplication were discussed individually
for each patient within a pulmonology board between pedi-
atricians and surgeons, after evaluation of mentioned di-
agnostic findings. Surgery was performed after ineffective
medical treatment which was administered over a period
of 6–12 months and resulted in worsening or recurrence of
symptoms after drug discontinuation, during the treatment
itself, or because family compliance was lacking.
A laparoscopic four-trocar 360Nissen fundoplication was
performed in all patients. With regard to operative technique,
the operation included three steps in each case as follows: (1)
dissection of the gastroesophageal junction and the lower
esophagus; (2) crural repair; and (3) formation of a 360wrap
using nonresorbable sutures.
Patients’ records were analyzed with regard to the follow-
ing: outcome of surgery, postoperative complications, relapse
of disease and need for reoperations, and outcome of respi-
ratory complaints after surgical treatment.
To objectively evaluate postoperative outcome of both
upper gastrointestinal symptoms and respiratory complaints
in our patients, we applied the modified Visick classification
and the Cough Symptom Score (CSS). The Visick grading
system is used to assess the subjective effect of antireflux
surgery, evaluating resolution, persistence, or worsening of
the symptoms, impact of surgery on quality of life, and need
for medications after surgery (Table 1). The CSS is a 5-point
scale aiming to assess the severity of the cough and the pa-
tient’s perception (Table 2).
The study received the appropriate institutional review
board approval. Statistical analysis was carried out using the
Statistical Package for Social Sciences (SPSS, Inc., Chicago,
IL), version 13.0. Data were compared using the Student’s t-
test. Significance was defined as P < .05.
Results
A total of 220 laparoscopic Nissen procedures were per-
formed in all centers during the period 2005–2015. Twenty-
four out of the 220 patients (10.9%) presented with GERD-
related respiratory symptoms. There were 12 boys and 12
girls, with an average age of 9.5 years (range 6.5–17 years).
The average weight of patients was 29 kg (range 15–65 kg).
Chronic cough was the principal symptom in 20 patients
(83.3%), whereas in the remaining 4 children (16.7%) the
main respiratory manifestations included asthma, reactive
airway disease, and recurrent pneumonia. In most patients, the
respiratory symptoms, especially the cough, were so strong
Table 1. The Modified Visick Classification
Grade Characteristics
I Asymptomatic
II Mild symptoms. Quality of life unaffected. No
medication needed
III Moderate symptoms. Quality of life unaffected.
Medication required
IV Recurrent, incapacitating symptoms equal or worse
to preoperative situation























































that it limited their scholar and social activity. Age of onset of
respiratory symptoms was <1 year in 15 cases (62.5%).
Nocturnal symptoms of cough and wheeze were noted in
13/24 patients (54.1%). None of the cases of GERD-related
reactive airway disease had a family history of asthma.
Only 3 cases (12.5%) had typical gastrointestinal symp-
toms attributed to GER. The other 21 cases (87.5%) did not
have any gastrointestinal symptoms of GER.
Pathologies associated were esophagitis in 4 patients and
Barrett’s esophagus in 2 children.
Fourteen out of the 24 cases (58.3%) were detected to have
severe reflux, 7 patients (29.1%) presented moderate reflux,
and 3 patients (12.5%) hadmild reflux. The DeMeester scores
ranged from 20 to 240 (average 42), with 55% showing an
association between reflux and respiratory symptoms.
Eight patients (33.4%) had a preoperative bronchoscopy
and BAL, and all of them had significant granulocytosis and
LLAM (>5%) in their BAL samples.
Before surgery, all patients were treated with antireflux
therapy for 6–12 months and after failure of medical treat-
ment they were candidates to fundoplication. Fourteen pa-
tients (58.3%) were treated preoperatively with inhalative
steroids and inhalative beta-2-mimetics, whereas 8 patients
(33.3%) received oral steroids.
Average operative time was 65 minutes (range 45–100).
No conversion to open surgery was reported. As for postop-
erative outcome, following four complications were reported
with an overall complication rate of 1.8% (4/220): two tight
wraps requiring endoscopic dilatation (IIIb Clavien) and two
relapses of GERD for slipped Nissen requiring reoperation
(IIIb Clavien). None of these complications occurred in the
group of patients with GERD-related respiratory symptoms.
Average follow-up length was 7 years (range 2–12). Pa-
tients were assessed with anamnestic evaluation and physical
examination at 1, 3, 6, and 12 months after surgery and there-
after with annual clinical controls. Radiologic examinations
were performed only in presence of postoperative symptoms
or other problems.
At clinical controls, respiratory symptoms disappeared com-
pletely with a significant improvement of quality of life scor-
ing in 22/24 patients (91.6%) after 2.8– 4.6 months. In fact,
these 22 patients (91.6%) were assessed as Grade I according
to Visick classification as they were asymptomatic, with no
need for any medication and improved quality of life, whereas
the remaining 2 patients (8.4%) were classified as Grade III
according to Visick as they presented moderate symptoms
with persistent need for medications and quality of life unaf-
fected. These 2 patients with postoperative persistence of re-
spiratory symptoms were managed by pulmonologists.
In regard to assessment of the cough severity, the 20 pa-
tients with GERD-related chronic cough recorded a preop-
erative CSS daytime average score of 4.3 – 0.5 and a CSS
nighttime average score of 3.8 – 0.4. Postoperatively, both
FIG. 1. Course of postoperative medication.
Table 2. The Cough Symptom Score
Daytime
0 =No cough
1 =Cough for one short period
2 =Cough for more than two short periods
3 = Frequent cough not interfering with usual activities
4 = Frequent cough interfering with usual activities
5 =Distressing cough most of the day
Nighttime
0 =No cough
1 =Cough on waking only/cough on going to sleep only
2 =Awoken once or woken early due to coughing
3 = Frequent waking due to coughing
4 = Frequent coughs most of the night
5 =Distressing cough























































CSS daytime (0– 0.7) and nighttime (0– 0.5) average scores
significantly improved in all these patients (P = .001).
In regard to postoperative medication course, 85.7% of
patients receiving inhalative steroids and inhalative beta-2-
mimetics were completely weaned after 5.4 – 2.6 months,
while 14.3% significantly reduced their usage after 4.5 – 3.9
months. Of those patients receiving oral steroids, 100% were
completely weaned after 4.4 – 3.1 months. Of the patients,
95.8% discontinued their use of PPI after 0.3 – 0.8 months,
while 4.2% of patients significantly reduced their usage after
1 month (Fig. 1).
All patients’ demographics and outcome parameters are
reported in Table 3.
Discussion
The relationship between GERD and respiratory disease in
infants and children has been shown to be present in many
forms.1,17 Hoarseness, sore throat, chronic cough, bronchitis,
asthma, recurrent pneumonia, chest pain, and ear pain are the
most common respiratory complaints reported. Epidemiolo-
gic data show that pulmonary symptoms occur in up to 50%
of patients with GERD.21
Several studies have shown that intensive medical man-
agement of GERD often fails to have any effect on the pa-
tients’ respiratory symptoms. Shapiro and Christie reported a
significant correlation between GERD and steroid-dependent
asthma, but failed to show an improvement in their airway
disease during a 3-week period of intensive medical therapy
for their GER.22 Fonkalsrud et al. suggested that in this subset
of patients, medical therapy may be inadequate and surgical
correction may be more efficacious. They reported that 90%
of their patients who failed to respond to medical therapy had
symptomatic improvement of their respiratory symptoms
after fundoplication.23 Rothenberg et al. showed that in this
subset of patients, medical therapy may be inadequate in
interrupting the reflex pathway between esophageal irritation
and bronchoconstriction, but that surgical correction may act
as a more effective barrier.20
Surgical management of GERD by fundoplication has re-
peatedly proven to be superior to medical therapy in children
with chronic airway disease (CAD) and GERD.6,24 Further
support comes from several studies describing a postoperative
improvement of respiratory symptoms and significant de-
crease in steroid and bronchodilator dose in 80%–90% of
patients.17,20 Our results confirmed this evidence as we ob-
tained a complete weaning from inhalative steroids and in-
halative beta-2-mimetics in 85.7% of our patients and a
significant reduction of these medications in 14.3% of cases.
The success of surgery depends on identifying patients
who are most likely to benefit from surgical intervention.25
Patients with pulmonary symptoms frequently have asymp-
tomatic GERD; as reported in our series, 87.5% of patients
did not have any gastrointestinal symptoms of GER. In this
group, a high index of suspicion is needed to identify GERD
as a contributing factor. A properly taken clinical history with
detailed questions about the character and timing of respi-
ratory and esophageal symptoms is helpful in finding suitable
candidates for antireflux surgery. When patients are chosen
appropriately, surgical therapy appears to be superior to
medical therapy for alleviating supraesophageal symptoms.21
Despite this evidence, pediatric gastroenterologists are often
very reluctant to confirm the indications for surgery in pediatric
patientswithGER and persistent respiratory symptoms because
they prefer to continue to treat these patients with only medical
therapy. In our series, in 5 patients with chronic cough not
responsive to medical therapy and causing an important in-
validation in their social and scholar activities, the surgical
indication was confirmed by pediatric surgeons in disagree-
ment with the pediatricians that were reluctant to candidate the
Table 3. Patients’ Demographics
and Outcome Parameters
Patients’ demographics
Total number of Nissen procedures 220
No. of Nissen in patients with GERD-
related respiratory symptoms
24/220 (10.9%)
No. of girls 12
No. of boys 12
Average age (years) 9.5




Reactive airway disease 1/24 (4.2%)
Recurrent pneumonia 1/24 (4.2%)
Nocturnal symptoms (cough, wheeze) 13/24 (54.1%)
Gastrointestinal symptoms 3/24 (12.5%)
Esophagitis 4/24 (16.6%)
Barrett’s esophagus 2/24 (8.3%)
Surgical outcome
Average operative time (minutes) 65
Conversion to open surgery 0
Intraoperative complications 0
Postoperative complications
Tight wraps requiring endoscopic
dilation (IIIb Clavien)
2/220 (0.9%)
Relapse of GERD 2/220 (0.9%)
Reoperations 4/220 (1.8%)
Average follow-up length (years) 7




Grade I 22/24 (91.6%)
Grade II 0
Grade III 2/24 (8.4%)
Grade IV 0
Average CSS: daytime
Preoperative 4.3 – 0.5
Postoperative 0 – 0.7 (P = .001)
Average CSS: nighttime
Preoperative 3.8 – 0.4
Postoperative 0 – 0.5 (P = .001)
Postoperative discontinuation of treatment
Inhalative steroids 12/14 (85.7%)
Oral steroids 8/8 (100%)
Inhalative beta-2-mimetics 12/14 (85.7%)
PPI 23/24 (95.8%)
CSS, Cough Symptom Score; GERD, gastroesophageal reflux
disease; PPI, proton pump inhibitors.























































patient to surgery. The parents agreed with the surgeons to
operate their children and the cough disappeared completely
without need of any medication, 2 months after surgery.
In addition, Rothenberg et al. described the reluctance of
some colleagues to refer CAD patients for surgical antireflux
procedures, for example, owing to the perceived surgical
morbidity in this subgroup.26
However, with the proven success of laparoscopic antire-
flux surgery even in those patients with severe respiratory
impairment, the threshold to refer patients for surgical therapy
has been lowered.27–30 Even in GERD patients with severe
pulmonary problems who would not otherwise tolerate an
abdominal operation, laparoscopic fundoplication can be
performed safely and with high success rate. The minimal
surgical trauma and postoperative pain associated with lapa-
roscopic fundoplication result in less splinting and inhibition
to deep breathing and coughing than seen in open surgery and
result in fewer respiratory complications.17 Our results are
consistent with most reports of the literature; in fact, none of
the postoperative complications reported in our series oc-
curred in patients with GERD-related respiratory complaints.
In contrast to medical therapy, surgery can correct the
antireflux barrier of the lower esophageal sphincter and re-
store the gastroesophageal junction by correcting the hia-
tal hernia.31 Surgery provides continuous control of reflux,
whereas medical therapy does not. Surgery prevents both
acid and nonacid reflux and promotes gastric emptying.
It is also important to offer surgery early in the course of
the disease to prevent the development of esophageal body
motility dysfunction. In fact, relief of GERD-associated re-
spiratory symptoms after antireflux surgery is not as good in
patients with impaired esophageal body motility.32
According to our experience, the surgical approach is
mandatory when GERD is the suspected cause of respiratory
complaints, and the response to medical therapy is partial or
temporary. We reported a very low reflux recurrence rate
(<1%) and complication risk (<2%), which suggest the effec-
tiveness of an early surgical treatment. More importantly, none
of the complications recorded in our series occurred in the
group of patients with GERD-related respiratory symptoms.
It is fundamental to manage these patients in a multidis-
ciplinary setting among pediatricians, pulmonologists, and
surgeons, and the indications for surgery have to be estab-
lished on an individual basis, according to the results of the
diagnostic workup.
Another important consideration is that, analyzing the
current pediatric literature, there are no reports of tools to
assess impact of chronic cough on quality of life, specifically
designed for pediatric patients. Adverse Cough Outcome
Survey and Sickness Impact Profile have been described as
valid tools to assess impact of chronic cough on quality of life
in adults, but they have never been applied to a pediatric
population.33 To objectively evaluate postoperative outcome
of both upper gastrointestinal symptoms and respiratory
complaints in our patients, we applied the modified Visick
classification34 and the CSS.35 Both these tools demonstrated
a significant postoperative improvement of the severity of the
symptoms, need for medications, and quality of life in most
patients of our series.
In conclusion, our results confirm that GERD should be
investigated as one of the possible etiologic factors in any child
with chronic cough or other persistent respiratory complaints.
In patients with symptoms not responsive to medical GER
therapy, laparoscopic Nissen fundoplication should be con-
sidered the treatment of choice with a very high success rate
(>90% in our series) and a very low morbidity rate. It allows
a significant improvement of respiratory symptoms with a
marked reduction in the need for medications and, conse-
quently, a significant improvement in the quality of life of
patients and their families.
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